Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 7/20 | 0.45 |
| ▸ | FDPS | P14324 | 11/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL167214 | 1.00 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL7875345 | 1.00 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL17941431 | 0.93 | GGPS1 (0.46) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL27489880 | 0.93 | GGPS1 (0.46) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL6321152 | 0.90 | GGPS1 (0.42) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL17941377 | 0.86 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL168831 | 0.86 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL10384666 | 0.86 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL17941481 | 0.86 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 | |
| SCHEMBL26604 | 0.86 | GGPS1 (0.45) | GGPS1FDPSSMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 792 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095066-A | Enzyme stabilization in protease inhibitor-containing compositions | — | 2026-05-26 | — | — | CN | disclosed |
| EP-3933019-B1 | PROCESS FOR MANUFACTURING A WATER-SOLUBLE UNIT DOSE ARTICLE | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO LTD (JP) | 2026-03-19 | — | — | US | disclosed |
| US-12529014-B2 | Polyurethane redeposition inhibiting polymers and detergent compositions containing same | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-3368592-B1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | DOW TORAY CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-12460160-B2 | Redeposition inhibiting styrene maleic anhydride copolymers and detergent compositions containing same | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4626941-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESSTHEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | Dow Toray Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| CN-120129707-A | Solid particles of silicone-functional copolymer, method for producing same, and cosmetic containing same | 陶氏东丽株式会社 | 2025-06-10 | — | — | CN | disclosed |
| WO-2025093368-A1 | ENZYME STABILIZATION IN COMPOSITIONS CONTAINING A PROTEASE INHIBITOR | BASF SE (DE) | 2025-05-08 | — | — | WO | disclosed |
| US-20250027013-A1 | Manganese Bleach Catalyst Granules | NOVOZYMES A/S (DK) | 2025-01-23 | — | — | US | disclosed |
| WO-1994007974-A1 | A DETERGENT COMPOSITION COMPRISING A LIME SOAP DISPERSING SURFACTANT | THE PROCTER & GAMBLE COMPANY (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1994007985-A1 | DETERGENT COMPOSITION COMPRISING LIME SOAP DISPERSANT AND LIPASE ENZYMES | THE PROCTER & GAMBLE COMPANY (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1994005758-A1 | LIQUID OR GEL DETERGENT COMPOSITIONS CONTAINING CALCIUM AND STABILIZING AGENT THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 1994-03-17 | — | — | WO | disclosed |
| EP-0550653-A1 | DETERGENT COMPOSITIONS CONTAINING POLYHYDROXY FATTY ACID AMIDES AND SUDS ENHANCING AGENT. | PROCTER & GAMBLE (US) | 1993-07-14 | — | — | EP | disclosed |
| WO-1992006161-A1 | DETERGENT COMPOSITIONS CONTAINING POLYHYDROXY FATTY ACID AMIDES AND SUDS ENHANCING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-16 | — | — | WO | disclosed |
| US-4681704-A | REMOVAL OF GREASY SOILS | THE PROCTER & GAMBLE COMPANY (US) | 1987-07-21 | — | — | US | disclosed |
| EP-0157443-A1 | Detergent composition containing semi-polar nonionic detergent, alkaline earth metal anionic detergent, and amidoalkylbetaine detergent | THE PROCTER & GAMBLE COMPANY (US) | 1985-10-09 | — | — | EP | disclosed |
| EP-0062371-B1 | LIQUID DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4435317-A | STABILIZATION; GREASE REMOVAL | THE PROCTER & GAMBLE COMPANY (US) | 1984-03-06 | — | — | US | disclosed |
| US-4133779-A | AMINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | FOXM1, FOXK1, TAF1L | GGPS1 439/4885FDPS 739/4885SMPD1 1890/4885 |
| US-12529014-B2 | Polyurethane redeposition inhibiting polymers and detergent compositions containing same | PUF60, XRCC6, SDC2 | GGPS1 2673/4885FDPS 4710/4885SMPD1 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.